NeuroMetrix (NURO) Reports Q2 Loss of $0.17

NeuroMetrix (NASDAQ: NURO) reported Q2 EPS of ($0.17). Revenue for the quarter came in at $2.1 million, versus $0 reported last year.

For earnings history and earnings-related data on NeuroMetrix (NURO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c